Abstract: An integrated circuit 2 comprises a functional circuit 4, 6 which is arranged to operate in response to an operational clock signal having an operational clock frequency. To conserve power, the clock signal is distributed across the integrated circuit 2 at a distribution clock frequency which is less than the operational clock frequency. A clock converter 10 is provided to convert the distribution clock signal into the operational clock signal for controlling operation of the functional circuit 4, 6.
Type:
Grant
Filed:
September 23, 2011
Date of Patent:
December 10, 2013
Assignee:
Cambridge
Inventors:
James Edward Myers, Edmond John Simon Ashfield
Abstract: This invention relates to the use of formulations comprising an amphipathic or lipophilic anti-oxidant, such as lycopene, and a solubilising agent, such as whey protein, in the treatment of atherosclerotic disorders. Methods and materials for the treatment of atherosclerotic disorders using such formulations are provided.